Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M70.2Revenue (TTM) $M31.6Net Margin (%)5.6Altman Z-Score0.7
Enterprise Value $M88.0EPS (TTM) $0.1Operating Margin %5.3Piotroski F-Score6
P/E(ttm)16.7Beneish M-Score-1.8Pre-tax Margin (%)-0.3Higher ROA y-yY
Price/Book1.410-y EBITDA Growth Rate %--Quick Ratio1.5Cash flow > EarningsN
Price/Sales3.05-y EBITDA Growth Rate %80.0Current Ratio2.5Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)2.2Higher Current Ratio y-yY
Dividend Yield %--PEG0.1ROE % (ttm)10.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M78.6ROIC % (ttm)2.7Gross Margin Increase y-yY

Gurus Latest Trades with NEPT

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

NEPT is held by these investors:



NEPT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Montgomery, Adrian TaylorDirector 2014-12-03Buy11,000$2.21-59.28view
Godin, AndréSenior Officer 2014-11-12Buy3,000$2.15-58.14view
Lemieux, PierreDirector or Senior Officer of Insider or Subsidiar 2014-11-12Buy5,000$2.19-58.9view
Godin, AndréSenior Officer 2014-11-11Buy8,000$2.12-57.55view
Ripplinger, JohnSenior Officer 2014-11-11Buy3,550$2.12-57.55view
Turcotte, MarioSenior Officer 2014-11-11Buy6,870$2.14-57.94view
Fitzgibbon, PierreDirector 2014-11-10Buy37,500$2.09-56.94view
Huart, BenoîtDirector 2014-11-10Buy7,000$2.03-55.67view
Lauzon, ClaudieSenior Officer 2014-11-10Buy2,400$2.08-56.73view
Le Bel, DominiqueSenior Officer 2014-11-10Buy10,000$2.01-55.22view

Press Releases about NEPT :

Quarterly/Annual Reports about NEPT:

    News about NEPT:

    Articles On GuruFocus.com
    Neptune and Enzymotec Reach Patent Agreement Ending All Litigation Apr 03 2017 
    Acasti Pharma Reports Second Quarter 2017 Financial Results Oct 11 2016 
    Neptune and Ingenutra Sign an Exclusive Worldwide Agreement for MaxSimil® Oct 07 2016 
    Neptune and Aker BioMarine Reach Important Patent Agreement, Recognizing the Patents' Strength and E Oct 03 2016 
    Neptune to Hold Conference Call to Discuss Second Quarter Results for the Period Ended August 31, 20 Sep 28 2016 
    NEPTUNE Introduces NKO(R) Omega Plus, a New and Innovative Krill Oil Product with one of the Highest Sep 15 2016 
    Acasti Pharma Reports Positive CaPre Omega-3 Bridging Study Data Sep 15 2016 
    Neptune to Hold Conference Call to Discuss First Quarter Results for the Period Ended May 31, 2016 Jun 30 2016 
    Neptune Announces Fourth Quarter and Fiscal Year Results May 25 2016 
    Acasti Announces Fourth Quarter and Fiscal Year Results May 25 2016 
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

    GF Chat

    {{numOfNotice}}
    FEEDBACK